Skip to main content
. 2017 Mar 7;7:43846. doi: 10.1038/srep43846

Figure 6. NMNAT2-specific neuroprotection assay.

Figure 6

Cell viability was evaluated by MTT reduction. DIV14 NMNAT2 WT, HET, or KO neurons were pretreated with DMSO or 10 uM of the indicated compounds for 6 hours and then exposed to either DMSO (blue) or drug + vincristine (magenta) for additional 6 hours. Statistical significance within each group was assessed by two-tailed T-test, and intergroup differences were assessed by one-way ANOVA. *Compared to DMSO only; #compared to DMSO + vincristine; $compared to drug + DMSO. */#/$p < 0.05, **/##/$$p < 0.001 ***/###/$$$p < 0.0001.